- +1-315-215-1633
- sales@thebrainyinsights.com
The global transcriptomics market was valued at USD 6.6 billion in 2022 and is anticipated to grow at a CAGR of 7.6 % from 2022 to 2030, The global transcriptomics market is expected to reach USD 11.85 billion by 2030. North America is expected to grow the fastest during the forecast period.
The study of the transcriptome, or transcriptomes, is known as transcriptomics. The entire collection of ribonucleic acid (RNA) molecules expressed in an organism, cell, or tissue is known as the transcriptome. Transcriptomics includes all facets of RNA, including levels, locations, functions, trafficking, and degradation of transcription and expression. The focus of academic scientific study and clinical medicine has firmly established itself in the field of genomics. Precision medicine, next-generation sequencing (NGS), and RNA-sequencing are a few examples of significant scientific and technological developments that have opened up new possibilities for public healthcare. Genetic polymorphisms and disease-diagnosis regions that are challenging to access with next-generation sequencing techniques are improved by emerging RNA sequencing. An increase in genomic studies has been made feasible by tremendous advancements in sequencing technologies and computational tools, which has led to an explosion of data. To extract potential insights from genomic project and initiative data, in-depth analyses are needed. Then, these revelations are applied to enhance clinical outcomes. To satisfy this critical need for genetic data analysis in the later phases, biotechnology companies are investing significantly in research and development (R&D) to broaden their respective bioinformatics pipelines for research and clinical applications. The global transcriptomics market is the next step in precision medicine and has the potential to transform patient care and public health.
Get an overview of this study by requesting a free sample
Increasing RNA-Sequencing and NGS Application to Drive Market- DNA and RNA analysis uses next-generation sequencing (NGS), also called high-throughput sequencing. In particular, next-generation sequencing (NGS) has transformed the diagnosis of genetic illnesses and allowed medical professionals to offer even more thorough clinical insights. The dynamic nature of the transcriptome may be examined and resolved in greater detail owing to RNA-sequencing. Recent advancements in RNA sequencing have significantly impacted sample preparation, sequencing, and data analysis. This helps analyze the transcriptome profiles and figure out whether or not certain physiological and pathological factors might be explained.
Costly, inadequate infrastructure, and lack of tools to impede market expansion- RNA-sequencing and next-generation sequencing are expensive processes. These approaches are thought to be executed through specific procedures such as DNA or RNA separation, library preparation, sequencing reagents, data interpretation, and storage. To undertake such a study, it is essential to have qualified experts who have received maintenance training. As a result, the lack of transparency surrounding transcriptomics research and expensive maintenance expenses impede the spread of technical information about this business. Data analysis for NGS and RNA sequencing requires computational tools; however, these tools are currently unavailable.
The development of research applications and the discovery of biomarkers will increase market opportunities- Given the rapid advancements in genomics and data analysis, it is imperative to understand how dynamic this subject is. Modern technologies are replacing older technologies to, more specifically, understand the complexity of genomic behavior in healthy and diseased individuals. It is important to remember that the transcriptomics market has tremendously advanced due to RNA-sequencing, microarray, PCR, and NGS. Technologies like NGS, determining the numerous elements influencing a successful disease diagnosis is becoming quicker and more precise. These breakthroughs provide a rare opportunity to increase significantly diagnostic data analysis and present chances to grow the global transcriptomics market.
Lack of efficient bioinformatics tools- Transcriptomic research using microarrays generates much data. As a result, interpreting results and using computer resources to handle data are frequently complex tasks for researchers. Additionally, the limited genome coverage and strong amplification bias of the RNA sequencing data from transcriptomics research make data interpretation extremely difficult, particularly in the absence of efficient bioinformatics tools. Numerous technologies created for bulk cell sequencing have not successfully analyzed transcriptomics data. In terms of calling copy number changes, locating mutant genes in tumor samples, reconstructing cell lineages, recovering low abundant transcripts, and increasing the precision of quantitative transcripts analysis, this presents various obstacles.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global transcriptomics market, with a 37.9% share of the market revenue in 2022.
North America currently dominates the transcriptomics market. The large market share of this industry sector can be attributed to the growth of structure-based drug designs, the expansion of academic and governmental funding for genomics and proteomics research, the high funding levels for life sciences research, the high R&D spending in the biopharmaceutical industry, and the increased uptake of cutting-edge technologies in North America. Another essential aspect of the substantial share of this market segment is the existence of numerous international competitors in this region.
North America Region Transcriptomics Market Share in 2022 - 37.9%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
Product Type segment analysis
The product type segment is divided into instruments, consumables, reagents, and software. The consumable segment dominated the market, with a market share of around 43% in 2022. Consumables like assays are used as research tools in molecular biology, pharmacology, laboratory medicine, and environmental biology to evaluate a target entity's presence, quantity, or functional activity in either a qualitative or quantitative way (the analyte).
Technology segment analysis
The technology segment is divided into NGS, microarrays, and sanger. Over the forecast period, the NGS segment is expected to grow at the fastest CAGR of 8.3%. The expansion of this segment has been spurred by recent technology developments such as sample multiplexing, thorough genome coverage, greater sensitivity, and concurrent broad genome sequencing. The use of next-generation sequencing (NGS) in genome research is growing.
Application segment analysis
The application segment is divided into drug discovery, toxicogenomics, comparative transcriptomics, and clinical diagnostics. In 2022, the drug discovery segment dominated the market, accounting for around 32.8% of global revenue. The discipline of transcriptomics, which encompasses single-cell RNA-sequencing (scRNA-seq) and high-plex imaging, offers substantial technological breakthroughs for the detection of biomarkers and the discovery of new therapeutics compared to the traditional methods of RNA-sequencing.
End-User segment analysis
The end-user segment is divided into CROs, academic & research institutes, hospitals, and pharmaceutical & biotechnology companies. The CRO segment dominated the market, accounting for around 29.6% of global revenue. CROs offer companies and academia accessible venues to explore the development of novel medications at a reasonable cost. Along with government agencies like the NIH and EMA, they also assist foundations, research centers, and universities. These elements are fueling this market segment's expansion.
| Attribute | Description |
|---|---|
| Market Size | Revenue (USD Billion), Volume (Kg) |
| Market size value in 2021 | USD 6.6 Billion |
| Market size value in 2030 | USD 11.85 Billion |
| CAGR (2022 to 2030) | 7.6 % |
| Historical data | 2019-2020 |
| Base Year | 2021 |
| Forecast | 2022-2030 |
| Segments | Product Type, Technology, Application, and End-User |
| Regional Segments | North America, Asia Pacific, Europe, Latin America, Middle East and Africa |
As per The Brainy Insights, the size of the transcriptomics market was valued at USD 6.6 billion in 2022 to USD 11.85 billion by 2030.
The global transcriptomics market is growing at a CAGR of 7.6% during the forecast period 2022-2030.
North America emerged as the largest market for transcriptomics.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Product Type
4.3.2. Market Attractiveness Analysis By Technology
4.3.3. Market Attractiveness Analysis By Application
4.3.4. Market Attractiveness Analysis By End-User
4.3.5. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing RNA-Sequencing and NGS Application to drive market
5.3. Restraints
5.3.1. Costly, inadequate infrastructure, and lack of tools to impede market expansion
5.4. Opportunities
5.4.1. The development of research applications and the discovery of biomarkers will increase market opportunities
5.5. Challenges
5.5.1. Lack of efficient bioinformatics tools
6. Global Transcriptomics Market Analysis and Forecast, By Product Type
6.1. Segment Overview
6.2. Instruments
6.3. Consumables
6.4. Reagents
6.5. Software
7. Global Transcriptomics Market Analysis and Forecast, By Technology
7.1. Segment Overview
7.2. NGS
7.3. Microarrays
7.4. Sanger
8. Global Transcriptomics Market Analysis and Forecast, By Application
8.1. Segment Overview
8.2. Drug Discovery
8.3. Toxicogenomics
8.4. Comparative Transcriptomics
8.5. Clinical Diagnostics
9. Global Transcriptomics Market Analysis and Forecast, By End-User
9.1. Segment Overview
9.2. CROs
9.3. Academic & Research Institutes
9.4. Hospitals
9.5. Pharmaceutical & Biotechnology Companies
10. Global Transcriptomics Market Analysis and Forecast, By Regional Analysis
10.1. Segment Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.5. South America
10.5.1. Brazil
10.6. Middle East and Africa
10.6.1. UAE
10.6.2. South Africa
11. Global Transcriptomics Market-Competitive Landscape
11.1. Overview
11.1.1. Market Share of Key Players in the Transcriptomics Market
11.1.2. Global Company Market Share
11.1.3. North America Company Market Share
11.1.4. Europe Company Market Share
11.1.5. APAC Company Market Share
11.2. Competitive Situations and Trends
11.2.1. Product Launches and Developments
11.2.2. Partnerships, Collaborations, and Agreements
11.2.3. Mergers & Acquisitions
11.2.4. Expansions
12. Company Profiles
12.1. Pacific Biosciences of California Inc.
12.1.1. Business Overview
12.1.2. Company Snapshot
12.1.3. Company Market Share Analysis
12.1.4. Company Component Portfolio
12.1.5. Recent Developments
12.1.6. SWOT Analysis
12.2. Thermo Fisher Scientific Inc.
12.2.1. Business Overview
12.2.2. Company Snapshot
12.2.3. Company Market Share Analysis
12.2.4. Company Component Portfolio
12.2.5. Recent Developments
12.2.6. SWOT Analysis
12.3. Agilent Technologies Inc.
12.3.1. Business Overview
12.3.2. Company Snapshot
12.3.3. Company Market Share Analysis
12.3.4. Company Component Portfolio
12.3.5. Recent Developments
12.3.6. SWOT Analysis
12.4. Illumina Inc.
12.4.1. Business Overview
12.4.2. Company Snapshot
12.4.3. Company Market Share Analysis
12.4.4. Company Component Portfolio
12.4.5. Recent Developments
12.4.6. SWOT Analysis
12.5. QIAGEN
12.5.1. Business Overview
12.5.2. Company Snapshot
12.5.3. Company Market Share Analysis
12.5.4. Company Component Portfolio
12.5.5. Recent Developments
12.5.6. SWOT Analysis
12.6. Bio-Rad Laboratories Inc.
12.6.1. Business Overview
12.6.2. Company Snapshot
12.6.3. Company Market Share Analysis
12.6.4. Company Component Portfolio
12.6.5. Recent Developments
12.6.6. SWOT Analysis
12.7. Takara Bio Inc.
12.7.1. Business Overview
12.7.2. Company Snapshot
12.7.3. Company Market Share Analysis
12.7.4. Company Component Portfolio
12.7.5. Recent Developments
12.7.6. SWOT Analysis
12.8. PerkinElmer Inc.
12.8.1. Business Overview
12.8.2. Company Snapshot
12.8.3. Company Market Share Analysis
12.8.4. Company Component Portfolio
12.8.5. Recent Developments
12.8.6. SWOT Analysis
12.9. Fluidigm Corporation
12.9.1. Business Overview
12.9.2. Company Snapshot
12.9.3. Company Market Share Analysis
12.9.4. Company Component Portfolio
12.9.5. Recent Developments
12.9.6. SWOT Analysis
12.10. 10X Genomics
12.10.1. Business Overview
12.10.2. Company Snapshot
12.10.3. Company Market Share Analysis
12.10.4. Company Component Portfolio
12.10.5. Recent Developments
12.10.6. SWOT Analysis
List of Table
1. Global Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
2. Global Instruments Transcriptomics Market, By Region, 2019-2030 (USD Billion)
3. Global Consumables Transcriptomics Market, By Region, 2019-2030 (USD Billion)
4. Global Reagents Transcriptomics Market, By Region, 2019-2030 (USD Billion)
5. Global Software Transcriptomics Market, By Region, 2019-2030 (USD Billion)
6. Global Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
7. Global NGS Transcriptomics Market, By Region, 2019-2030 (USD Billion)
8. Global Microarrays Transcriptomics Market, By Region, 2019-2030 (USD Billion)
9. Global Sanger Transcriptomics Market, By Region, 2019-2030 (USD Billion)
10. Global Transcriptomics Market, By Application, 2019-2030 (USD Billion)
11. Global Drug Discovery Transcriptomics Market, By Region, 2019-2030 (USD Billion)
12. Global Toxicogenomics Transcriptomics Market, By Region, 2019-2030 (USD Billion)
13. Global Comparative Transcriptomics Transcriptomics Market, By Region, 2019-2030 (USD Billion)
14. Global Clinical Diagnostics Transcriptomics Market, By Region, 2019-2030 (USD Billion)
15. Global Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
16. Global CROs Transcriptomics Market, By Region, 2019-2030 (USD Billion)
17. Global Academic & Research Institutes Transcriptomics Market, By Region, 2019-2030 (USD Billion)
18. Global Hospitals Transcriptomics Market, By Region, 2019-2030 (USD Billion)
19. Global Pharmaceutical & Biotechnology Companies Transcriptomics Market, By Region, 2019-2030 (USD Billion)
20. Global Transcriptomics Market, By Region, 2019-2030 (USD Billion)
21. North America Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
22. North America Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
23. North America Transcriptomics Market, By Application, 2019-2030 (USD Billion)
24. North America Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
25. U.S. Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
26. U.S. Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
27. U.S. Transcriptomics Market, By Application, 2019-2030 (USD Billion)
28. U.S. Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
29. Canada Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
30. Canada Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
31. Canada Transcriptomics Market, By Application, 2019-2030 (USD Billion)
32. Canada Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
33. Mexico Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
34. Mexico Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
35. Mexico Transcriptomics Market, By Application, 2019-2030 (USD Billion)
36. Mexico Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
37. Europe Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
38. Europe Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
39. Europe Transcriptomics Market, By Application, 2019-2030 (USD Billion)
40. Europe Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
41. Germany Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
42. Germany Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
43. Germany Transcriptomics Market, By Application, 2019-2030 (USD Billion)
44. Germany Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
45. France Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
46. France Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
47. France Transcriptomics Market, By Application, 2019-2030 (USD Billion)
48. France Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
49. U.K. Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
50. U.K. Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
51. U.K. Transcriptomics Market, By Application, 2019-2030 (USD Billion)
52. U.K. Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
53. Italy Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
54. Italy Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
55. Italy Transcriptomics Market, By Application, 2019-2030 (USD Billion)
56. Italy Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
57. Spain Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
58. Spain Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
59. Spain Transcriptomics Market, By Application, 2019-2030 (USD Billion)
60. Spain Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
61. Asia Pacific Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
62. Asia Pacific Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
63. Asia Pacific Transcriptomics Market, By Application, 2019-2030 (USD Billion)
64. Asia Pacific Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
65. Japan Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
66. Japan Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
67. Japan Transcriptomics Market, By Application, 2019-2030 (USD Billion)
68. Japan Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
69. China Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
70. China Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
71. China Transcriptomics Market, By Application, 2019-2030 (USD Billion)
72. China Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
73. India Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
74. India Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
75. India Transcriptomics Market, By Application, 2019-2030 (USD Billion)
76. India Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
77. South America Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
78. South America Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
79. South America Transcriptomics Market, By Application, 2019-2030 (USD Billion)
80. South America Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
81. Brazil Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
82. Brazil Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
83. Brazil Transcriptomics Market, By Application, 2019-2030 (USD Billion)
84. Brazil Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
85. The Middle East and Africa Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
86. The Middle East and Africa Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
87. The Middle East and Africa Transcriptomics Market, By Application, 2019-2030 (USD Billion)
88. The Middle East and Africa Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
89. UAE Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
90. UAE Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
91. UAE Transcriptomics Market, By Application, 2019-2030 (USD Billion)
92. UAE Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
93. South Africa Transcriptomics Market, By Product Type, 2019-2030 (USD Billion)
94. South Africa Transcriptomics Market, By Technology, 2019-2030 (USD Billion)
95. South Africa Transcriptomics Market, By Application, 2019-2030 (USD Billion)
96. South Africa Transcriptomics Market, By End-User, 2019-2030 (USD Billion)
List of Figures
1. Global Transcriptomics Market Segmentation
2. Transcriptomics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Transcriptomics Market Attractiveness Analysis By Product Type
9. Global Transcriptomics Market Attractiveness Analysis By Technology
10. Global Transcriptomics Market Attractiveness Analysis By Application
11. Global Transcriptomics Market Attractiveness Analysis By End-User
12. Global Transcriptomics Market Attractiveness Analysis By Region
13. Global Transcriptomics Market: Dynamics
14. Global Transcriptomics Market Share By Product Type (2022 & 2030)
15. Global Transcriptomics Market Share By Technology (2022 & 2030)
16. Global Transcriptomics Market Share By Application (2022 & 2030)
17. Global Transcriptomics Market Share By End-User (2022 & 2030)
18. Global Transcriptomics Market Share By Regions (2022 & 2030)
19. Global Transcriptomics Market Share By Company (2021)
This study forecasts global, regional, and country revenue from 2019 to 2030. Brainy Insights has segmented the global transcriptomics market based on the below-mentioned segments:
Global Transcriptomics Market by Product Type:
Global Transcriptomics Market by Technology:
Global Transcriptomics Market by Application:
Global Transcriptomics Market by End-User:
Global Transcriptomics Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date
